Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Taiwan
Clinical trial register · Taiwan

Clinical Trials in Taiwan

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2861 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:18 UTC
2861
Studies in scope
all four open statuses
1565
Recruiting now
open to new participants
340
Lead sponsors
across recruiting studies
Top sites
Taipei 27 Tainan 26 Taichung 24 Kaohsiung City 15 Taoyuan 8

Trials in this register

28 of 2861 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Recruiting
Daiichi Sankyo
Phase 1/2
268
Taichung
2026-10-16
Recruiting
A Study of DS-3939a in Participants With Solid Tumors
NCT07739966Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Daiichi Sankyo
Phase 1/2
400
Taichung, Tainan, Taipei
2026-10-13
Recruiting
Daiichi Sankyo
Phase 1/2
220
Taichung, Tainan, Taipei
2026-09-17
Recruiting
Daiichi Sankyo
Phase 3
686
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
2025-10-24
Recruiting
Daiichi Sankyo
Phase 3
710
Taichung, Tainan, Taipei
2025-09-30
Recruiting
Daiichi Sankyo
Phase 1
76
Taichung, Tainan, Taipei, Taoyuan City
2025-07-17
Recruiting
Daiichi Sankyo
Phase 3
510
Kaohsiung City, Taichung, Tainan, Taipei
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
582
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
2025-03-19
Recruiting
Daiichi Sankyo
Phase 3
726
Kaohsiung City, Tainan, Taipei, Taoyuan City
2025-02-27
Active, closed
Daiichi Sankyo
Phase 3
700
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan County
2024-11-19
Recruiting
Daiichi Sankyo
Phase 3
540
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
2024-05-21
Recruiting
Daiichi Sankyo
Phase 1/2
680
Taichung, Tainan, Taipei
2024-04-10
Recruiting
Daiichi Sankyo
Phase 2/3
860
Taichung, Tainan, Taipei, Taoyuan City
2024-02-27
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
Daiichi Sankyo
Phase 2
740
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2024-02-26
Recruiting
Daiichi Sankyo
Phase 3
75
Tainan, Taipei
2024-01-05
Recruiting
Daiichi Sankyo
Phase 1
128
Tainan, Taipei
2023-05-30
Active, closed
Daiichi Sankyo
Phase 3
1,233
Changhua, Hsia, Taichung, Tainan, Taipei, Taoyuan
2023-01-11
Active, closed
Daiichi Sankyo
Phase 3
586
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2022-07-08
Active, closed
Daiichi Sankyo
Phase 2
187
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2022-03-09
Active, closed
Daiichi Sankyo
Phase 3
740
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2022-03-04
Active, closed
Daiichi Sankyo
Phase 2
155
Kaohsiung City, Tainan, Taipei, Taoyuan City
2021-06-03
Active, closed
Daiichi Sankyo
Phase 3
490
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2021-05-21
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Daiichi Sankyo
Phase 2
277
Tainan, Kaohsiung City, Niaosong, Taichung, Taipei, Taoyuan
2021-02-02
Active, closed
Daiichi Sankyo
Phase 3
605
Kaohsiung City, Niaosong, Taichung, Tainan, Taipei, Taoyuan
2020-12-21
Active, closed
Daiichi Sankyo
Phase 3
1,600
Kaohsiung City, Beitou, Chang-hua, Taichung, Tainan, Taipei
2020-12-04
Active, closed
Daiichi Sankyo
Phase 1
312
Taichung, Tainan, Taipei
2017-10-30
Rows per page Showing 1–28 of 28
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-taiwan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,861 studies in total at the last sync on 15 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 28 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Taiwan?

15 of the 28 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 28 studies
PhaseStudiesRecruitingShare
Phase 314750%
Phase 15217.9%
Phase 1/24414.3%
Phase 24114.3%
Phase 2/3113.6%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Daiichi Sankyo2815

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Non-small Cell Lung Cancer (3) Gastric Cancer (2) Recurrent or Metastatic Solid Tumors (2) Metastatic Non Small Cell Lung Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (2) Advanced Solid Tumor (2) Esophageal Squamous Cell Carcinoma (1) Non-Small Cell Lung Cancer Metastatic (1) Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (1) Hormone Receptor Positive (1) HER2-low or HER2-ultralow (1) Unresectable or Metastatic Breast Cancer (1) Gastroesophageal Junction Cancer (1) Small Cell Lung Cancer (1) Advanced Cancer (1)
→

Browse trials by site location

Taipei (27) Tainan (26) Taichung (24) Kaohsiung City (15) Taoyuan (8) Taoyuan City (7) Changhua (1) Chang-hua (1) Taoyuan County (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.